国际麻醉学与复苏杂志   2021, Issue (10): 3-3
    
丘脑室旁核谷氨酸能神经元参与艾司氯胺酮麻醉觉醒作用机制研究
张芸芸, 刘畑畑, 张欣欣, 李傲, 杨谦梓, 董海龙1()
1.空军军医大学西京医院麻醉与围术期医学科
Study on the mechanism of glutamatergic neurons in paraventricular nucleus of thalamus involved in anesthesia and emergence of s‑ketamine
 全文:
摘要:

目的 探讨丘脑室旁核(paraventricular nucleus of thalamus, PVT)谷氨酸能神经元在艾司氯胺酮麻醉中的调控作用。 方法 研究全部选择8~10周龄雄性Vglut2‑cre转基因小鼠。取3只小鼠在PVT区立体定位注射钙信号病毒rAAV‑ EF1α‑DIO‑GCaMp6s‑WPRE‑hGH pA,3周后采用钙信号光纤记录技术观察艾司氯胺酮麻醉前后PVT谷氨酸能神经元的活性变化。取10只小鼠采用随机数字表法分为光遗传激活组(ChR2组)和光遗传对照病毒组(mCherry1组),每组5只,分别在PVT区立体定位注射兴奋性光遗传学病毒rAAV‑EF1α‑DIO‑hChR2(H134R)‑mCherry‑WPRE‑hGH pA或对照病毒rAAV‑EF1a‑ mCherry‑WPRE‑hGH pA,并埋置刺激光纤,3周后采用光遗传学技术激活PVT谷氨酸能神经元,观察麻醉维持期mCherry1组和ChR2组脑电频谱及各频段百分比总功率变化。取16只小鼠采用随机数字表法分为化学遗传抑制组(hM4Di组)和化学遗传对照病毒组(mCherry2组),每组8只,分别在PVT区立体定位注射抑制性化学遗传病毒rAAV‑EF1α‑DIO‑hM4D(Gi)‑mCherry‑ WPREs pA或对照病毒,3周后采用化学遗传学技术抑制PVT谷氨酸能神经元,观察mCherry2组和hM4Di组诱导时间和觉醒时间的变化。 结果 与清醒基线比较:PVT谷氨酸能神经元钙信号在麻醉诱导期明显增加(P<0.05),持续300~500 s,麻醉期明显下降(P<0.05),小鼠翻正反射恢复(recovery of righting reflex, RORR)后钙信号与麻醉期比较差异无统计学意义(P>0.05),但其低于清醒基线水平(P<0.05)。采用光遗传学方法激活PVT谷氨酸能神经元:与刺激前比较,ChR2组刺激中δ频段的百分比总功率明显下降(P<0.05),α频段的百分比总功率明显增加(P<0.05),其他频段差异无统计学意义(P>0.05)。化学遗传抑制PVT谷氨酸能神经元:与mCherry2组比较,hM4Di组觉醒时间延长(P<0.01),但两组诱导时间差异无统计学意义(P>0.05)。 结论 PVT谷氨酸能神经元参与艾司氯胺酮麻醉和觉醒过程,激活PVT谷氨酸能神经元可促进艾司氯胺酮麻醉觉醒。

关键词: 麻醉,全身; 觉醒; 艾司氯胺酮; 丘脑室旁核; 谷氨酸能神经元
Abstract:

Objective To investigate the role of glutamatergic neuron of paraventricular nucleus of the thalamus (PVT) in regulating s‑ketamine induced anesthesia. Methods In the current study, male Vglut2‑cre transgenic mice, aged 8 to 10 weeks, were selected. Three of the mice were stereotaxically injected with calcium signaling virus rAAV‐EF1α‐DIO‐GCaMp6s‐WPRE‐hGH pA in PVT area, after 3 weeks calcium imaging and fiber photometry were used to record the activity of PVT glutamatergic neurons before and after anesthesia with s‑ketamine. According to the random number table method, ten mice were divided into two groups (n=5): a ChR2 group and a mCherry1 group. Excitatory optogenetic virus rAAV‐EF1α‐DIO‐hChR2(H134R)‐mCherry‐WPRE‐hGH pA or control virus rAAV‐EF1a‐mCherry‐WPRE‐hGH pA was stereotaxically injected into PVT area, after 3 weeks optogenetics was used to activate PVT glutamatergic neurons. The changes of EEG spectrum and percentage of total power of each frequency band in the mCherry1 group and ChR2 group were observed. Furthermore, according to the random number table method, 16 mice were divided into two groups (n=8): a chemogenetic inhibition (hM4Di) group and a control virus (mCherry2) group. Inhibitory chemogenetic virus rAAV‐EF1α‐DIO‐hM4D(Gi)‐mCherry‐WPREs pA or control virus was stereotaxically injected into PVT area after 3 weeks. The glutamatergic neurons of PVT were inhibited by chemogenetic technique, and the induction and emergence time in the mCherry2 group and hM4Di group were observed. Results Compared with the awake baseline, the calcium signal of glutamatergic neurons in PVT increased significantly during induction period of s‑ketamine anesthesia (P<0.05), lasting about 300‒500 s. During anesthesia state, the calcium signal decreased significantly (P<0.05). There was no statistical significance in calcium signal after recovery of righting reflex (RORR) compared with anesthesia state (P>0.05), but it was lower than awake baseline (P<0.05). PVT glutamatergic neurons were activated by optogenetics technique, and the percentage of total power in δ band in ChR2 group was significantly decreased compared with that before stimulation (P<0.05), the percentage of total power in α band increased significantly (P<0.05), and there was no significant difference in other frequency bands (P>0.05). Chemogenetic inhibition of PVT glutamate neurons, compared with mCherry2 group, hM4Di group had longer emergence time (P<0.01), but there was no significant difference in induction time (P>0.05). Conclusions PVT glutamatergic neurons are involved in the anesthesia and arousal process of s‑ketamine. Activation of PVT glutamatergic neurons can promote emergence from anesthesia induced by s‑ketamine.

Key words: Anesthesia, general; Emergence; S‑ketamine; Periventricular nuclei of thalamus; Glutamatergic neuron